ZA9810679B - Antimicrobial peptides. - Google Patents

Antimicrobial peptides.

Info

Publication number: ZA9810679B
Authority: ZA; South Africa
Prior art keywords: seq; peptides; antimicrobial peptides; dmpiqafllyqqpvlgpvr; avestvatledspeviesppe
Prior art date: 1997-11-24

Application number

ZA9810679A

Other languages

English (en)

Inventor

Eric Charles Reynolds

Stuart Geoffrey Dashper

Neil Martin O'brien-Simpson

Gert Hoy Talbo

Marina Malkoski

Original Assignee

Univ Melbourne

Victorian Dairy Ind

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-24

Filing date

1998-11-23

Publication date

1999-07-30

1998-11-23 Application filed by Univ Melbourne, Victorian Dairy Ind filed Critical Univ Melbourne

1999-07-30 Publication of ZA9810679B publication Critical patent/ZA9810679B/xx

Links

102000044503 Antimicrobial Peptides Human genes 0.000 title abstract 2
108700042778 Antimicrobial Peptides Proteins 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
239000005018 casein Substances 0.000 abstract 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
235000021240 caseins Nutrition 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oral & Maxillofacial Surgery (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Birds (AREA)
Biophysics (AREA)
Dermatology (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Peptides Or Proteins (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA9810679A 1997-11-24 1998-11-23 Antimicrobial peptides. ZA9810679B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AUPP0514A AUPP051497A0 (en)	1997-11-24	1997-11-24	Antimicrobial peptides

Publications (1)

Publication Number	Publication Date
ZA9810679B true ZA9810679B (en)	1999-07-30

Family

ID=3804794

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9810679A ZA9810679B (en)	1997-11-24	1998-11-23	Antimicrobial peptides.

Country Status (9)

Country	Link
US (1)	US7588752B2 (fr)
EP (1)	EP1032592B1 (fr)
JP (1)	JP4940439B2 (fr)
AT (1)	ATE368053T1 (fr)
AU (1)	AUPP051497A0 (fr)
CA (1)	CA2311389C (fr)
DE (1)	DE69838143T2 (fr)
WO (1)	WO1999026971A1 (fr)
ZA (1)	ZA9810679B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPP494798A0 (en) *	1998-07-29	1998-08-20	Pacific Biolink Pty Limited	Protective protein formulation
GB0001825D0 (en) *	2000-01-26	2000-03-22	Regen Therapeutics Plc	Peptides
US7666996B2 (en) *	2000-03-01	2010-02-23	Peptera Pharmaceuticals Ltd	Casein derived peptides and uses thereof
IL134830A0 (en) *	2000-03-01	2001-05-20	Chay 13 Medical Res Group N V	Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
RU2305547C2 (ru)	2001-08-23	2007-09-10	Вестгейт Байолоджикал Лимитед	Применение апопротеинов сыворотки молока в профилактике или лечении микробной или вирусной инфекции
KR100944204B1 (ko)	2001-09-15	2010-02-26	러쉬 유니버시티 메디컬 센터	중층 연골 조직 및 그것을 조작하는 방법
US20030165574A1 (en) *	2002-03-01	2003-09-04	Ward Loren Spencer	Compositions and methods for treatment of body weight conditions
US7790670B2 (en)	2002-03-01	2010-09-07	Glanbia Nutritionals (Ireland) Ltd.	Compositions and methods for treatment of body weight conditions
KR100441402B1 (ko) *	2002-03-26	2004-07-23	한국과학기술원	항균 활성을 갖는 펩타이드, 이들의 유도체 및 이들을포함하는 항균 조성물
AU2003231471A1 (en)	2002-04-25	2003-11-10	Toagosei Co., Ltd.	Antimicrobial polypeptide and utizliation thereof
US8778889B2 (en)	2003-03-10	2014-07-15	The United States Of America As Represented By The Secretary Of The Army	Antimicrobial decapeptide oral hygiene treatment
DE10331202A1 (de)	2003-07-10	2005-03-31	S.K. Enterprise Gmbh	Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
US7220405B2 (en) *	2003-09-08	2007-05-22	E. I. Du Pont De Nemours And Company	Peptide-based conditioners and colorants for hair, skin, and nails
JP4524671B2 (ja)	2003-10-29	2010-08-18	東亞合成株式会社	抗菌ペプチド及びその利用
WO2005058344A1 (fr) *	2003-12-19	2005-06-30	The University Of Melbourne	Composition anti-microbienne
JP4507080B2 (ja)	2004-07-30	2010-07-21	東亞合成株式会社	抗菌ペプチド及びその利用
JP4656288B2 (ja) *	2004-08-19	2011-03-23	ライオン商事株式会社	動物用オーラルケア用ペットフードの製造方法
JP4730584B2 (ja)	2004-12-06	2011-07-20	東亞合成株式会社	抗菌ペプチド及びその利用
JP5041231B2 (ja)	2005-02-15	2012-10-03	東亞合成株式会社	抗菌ペプチド及びその利用
US7754687B2 (en) *	2005-02-24	2010-07-13	Mount Sinai School Of Medicine	Methods of inhibiting viral infection
ES2319475B1 (es)	2005-06-08	2010-02-16	Consejo Superior Investig. Cientificas	Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
JP2009516645A (ja) *	2005-10-18	2009-04-23	ザユー．エス．ガバメントアズリプレゼンテッドバイザセクレタリーオブジアーミー	抗菌デカペプチド口腔衛生処置
DE102006036285A1 (de) *	2006-08-03	2008-02-07	"S.U.K." Beteiligungs Gmbh	Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
US20080264479A1 (en)	2007-04-25	2008-10-30	Nanoco Technologies Limited	Hybrid Photovoltaic Cells and Related Methods
WO2009033824A1 (fr) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Utilisation d'une combinaison de bêta-casoquinine et de cnp-22 en tant qu'agent thérapeutique
US20100184684A1 (en) *	2009-01-06	2010-07-22	C3 Jian, Inc.	Antibacterial and antifungal peptides
US20110104179A1 (en) *	2009-06-19	2011-05-05	Oral Health Australia Pty Ltd	Protease inhibitory peptides
AU2010317661A1 (en) *	2009-11-11	2012-05-31	Oral Health Australia Pty Ltd	Antibiofilm glycopeptides
RU2415943C1 (ru) *	2010-02-16	2011-04-10	Оксана Васильевна Козлова	Биологически активный пептид, полученный из молочного белка
WO2013137805A1 (fr) *	2012-03-13	2013-09-19	Professor Sigge & Martin Ab	Système de gel naturel protecteur
ITMI20122263A1 (it)	2012-12-28	2014-06-29	Azienda Ospedaliero Universitaria Di Parma	Nuovi peptidi cationici ciclici ad attività antimicrobica
CN113045628B (zh) *	2021-03-23	2022-06-14	山东大学	一种抗菌肽或其变体在制备抗菌产品中的应用
CN113717267B (zh) *	2021-09-02	2023-02-28	湖南师范大学	一种抗菌肽pHTP-1及其应用和包含抗菌肽pHTP-1的产品
CN113717254B (zh) *	2021-09-23	2022-03-22	中山大学附属口腔医院	一种抗菌肽及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1315480C (fr) *	1986-06-12	1993-03-30	Eric Charles Reynolds	Phosphopeptides
CH671879A5 (fr) *	1987-02-26	1989-10-13	Nestle Sa
ES2084150T3 (es) *	1989-12-22	1996-05-01	Commw Scient Ind Res Org	Aminoacidos, peptidos o sus derivados asociados a las grasas.
US5583198A (en) *	1989-12-22	1996-12-10	Commonwealth Scientific And Industrial Research Organization	Amino acids, peptides or derivatives thereof coupled to fats
FR2686085B1 (fr) *	1992-01-10	1995-08-04	Agronomique Inst Nat Rech	Peptides representant des fragments du cmp, anticorps diriges contre lesdits peptides, et leurs utilisations.
JPH07278013A (ja) *	1994-03-31	1995-10-24	Snow Brand Milk Prod Co Ltd	エンドトキシン中和剤
GB9409387D0 (en)	1994-05-11	1994-06-29	Unilever Plc	Glucan-binding domains (gbp's) and hybird proteins containing gbd's as novel active systems targeted to dental plaque
JPH092926A (ja) *	1995-04-12	1997-01-07	Quest Internatl Bv	口内組成物

1997
- 1997-11-24 AU AUPP0514A patent/AUPP051497A0/en not_active Abandoned
1998
- 1998-11-23 ZA ZA9810679A patent/ZA9810679B/xx unknown
- 1998-11-24 CA CA2311389A patent/CA2311389C/fr not_active Expired - Fee Related
- 1998-11-24 AT AT98956720T patent/ATE368053T1/de not_active IP Right Cessation
- 1998-11-24 DE DE69838143T patent/DE69838143T2/de not_active Expired - Lifetime
- 1998-11-24 JP JP2000522127A patent/JP4940439B2/ja not_active Expired - Fee Related
- 1998-11-24 WO PCT/AU1998/000972 patent/WO1999026971A1/fr not_active Ceased
- 1998-11-24 EP EP98956720A patent/EP1032592B1/fr not_active Expired - Lifetime
2002
- 2002-10-24 US US10/280,833 patent/US7588752B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69838143D1 (de)	2007-09-06
ATE368053T1 (de)	2007-08-15
US20030195150A1 (en)	2003-10-16
CA2311389C (fr)	2011-02-15
JP2002503641A (ja)	2002-02-05
US7588752B2 (en)	2009-09-15
EP1032592A4 (fr)	2004-10-20
WO1999026971A1 (fr)	1999-06-03
DE69838143T2 (de)	2008-04-10
AUPP051497A0 (en)	1997-12-18
EP1032592B1 (fr)	2007-07-25
CA2311389A1 (fr)	1999-06-03
HK1030551A1 (en)	2001-05-11
JP4940439B2 (ja)	2012-05-30
EP1032592A1 (fr)	2000-09-06

Publication	Publication Date	Title
ZA9810679B (en)	1999-07-30	Antimicrobial peptides.
EP1803733A3 (fr)	2007-10-31	Traitement de l'inflammation
NZ503850A (en)	2002-12-20	April - a novel protein with growth effects
IL113617A0 (en)	1995-08-31	Soluble polypeptide fraction
AU4778101A (en)	2001-10-03	Novel polypeptides, and nucleic acids encoding the same
MX353234B (es)	2018-01-08	Variantes de polipeptidos con función efectora alterada.
EP1939293A3 (fr)	2008-07-09	Protéine ZCYTO21 d'interféron
NZ504548A (en)	2003-06-30	Polypeptides and nucleic acids encoding human chordin
GB9606040D0 (en)	1996-05-22	Active peptide
EP0733071A4 (fr)	1997-02-26	Antagonistes de la chaperonine 10
EP1006126A3 (fr)	2000-10-25	Peptide possedant une activité ostéogénique
CA2020663A1 (fr)	1991-01-08	Analogues de substitution de magainin peptides
AU3850997A (en)	1998-03-06	Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines
HU9601232D0 (en)	1996-06-28	Tomato xyloglucan endo-transglicosylase
AU5776799A (en)	2000-03-14	Modified hcv peptide vaccines
NZ518772A (en)	2003-03-28	Polypeptide fragments comprising c-terminal portion of helicobacter catalase
PT773999E (pt)	2002-08-30	Receptor orfao or-1 pertencente a familia de receptores nucleares
EP0919621A4 (fr)	2000-04-12	Tak1 humaine et adn codant celle-ci
EP0858808A3 (fr)	1999-08-25	Peptides applicables au traitement de lésions
EP2143730A3 (fr)	2011-06-29	Peptides modifiés et leur utilisation pour le traitement des maladies auto-immunes
EP0490383A3 (en)	1993-06-30	Peptides of the hiv-gag protein, their preparation and use
EP0723016A3 (fr)	1997-08-20	Facteur d'activation des leukocytes
WO2002030975A3 (fr)	2003-04-24	Composé fongicide
CA2244928A1 (fr)	1999-03-26	Adn codant pour une serine/threonine-kinase
DE60036676D1 (de)	2007-11-22	G-protein-gekoppelter rezeptor-ähnliche proteine